NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
PURDUE PHARMACEUTICAL PRODUCTS L.P.,
PURDUE PHARMA L.P., TRANSCEPT
PHARMACEUTICALS, INC., NKA PARATEK
PHARMACEUTICALS, INC.,
Plaintiffs-Appellants
v.
ACTAVIS ELIZABETH LLC, NOVEL
LABORATORIES, INC., DR. REDDY'S
LABORATORIES, INC., DR. REDDY'S
LABORATORIES, LTD.,
Defendants-Appellees
PAR PHARMACEUTICAL, INC.,
TWI PHARMACEUTICALS, INC.,
Defendants
______________________
2015-1659
______________________
Appeal from the United States District Court for the
District of New Jersey in Nos. 2:12-cv-05311-JLL-JAD,
2:13-cv-05003-JLL-JAD, Judge Jose L. Linares.
______________________
JUDGMENT
______________________
CHRISTOPHER NEIL SIPES, Covington & Burling LLP,
Washington, DC, argued for plaintiffs-appellants. Also
represented by ERICA NICOLE ANDERSEN, MICHAEL N.
KENNEDY.
JACOB M. HOLDREITH, Robins Kaplan LLP, Minneap-
olis, MN, argued for all defendants-appellees. Defendant-
appellee Novel Laboratories, Inc. also represented by
MILES FINN, JEFFREY ALAN HOVDEN, OREN D. LANGER,
New York, NY.
SAMUEL S. PARK, Winston & Strawn LLP, Chicago, IL,
for defendant-appellee Actavis Elizabeth LLC. Also repre-
sented by DAN HOANG; CHARLES B. KLEIN, Washington,
DC.
JEFFREY B. ARNOLD, Cantor Colburn LLP, Atlanta,
GA, for defendants-appellees Dr. Reddy’s Laboratories,
Inc., Dr. Reddy’s Laboratories, Ltd. Also represented by
STEVEN M. COYLE, NICHOLAS GEIGER, Hartford, CT.
______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (LOURIE, DYK, and HUGHES, Circuit
Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
January 8, 2016 /s/ Daniel E. O’Toole
Date Daniel E. O’Toole
Clerk of Court